Krystal Biotech, Inc. (KRYS)
282.96
-8.83
(-3.03%)
USD |
NASDAQ |
Jan 15, 15:39
Krystal Biotech SG&A Expense (TTM): 136.75M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| DexCom, Inc. | 1.297B |
| BioLife Solutions, Inc. | 56.57M |
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Catalyst Pharmaceuticals, Inc. | 162.44M |
| Amicus Therapeutics, Inc. | 353.07M |